Is Booster Dose Strategy Sufficient for Omicron Variant of SARS-CoV-2?

被引:36
作者
Chavda, Vivek P. [1 ]
Apostolopoulos, Vasso [2 ,3 ]
机构
[1] LM Coll Pharm, Dept Pharmaceut & Pharmaceut Technol, Ahmadabad 380008, Gujarat, India
[2] Victoria Univ, Inst Hlth & Sport, Melbourne, Vic 3030, Australia
[3] Australian Inst Musculoskeletal Sci AIMSS, Immunol Program, Melbourne, Vic 3021, Australia
关键词
Omicron variant; SARS-CoV-2; booster dose; vaccine;
D O I
10.3390/vaccines10030367
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The Omicron variant of SARS-CoV-2 is emerging in communities where people were previously infected with SARS-CoV-2 and are now being vaccinated, or where many people have received two or three coronavirus vaccination doses. More than 130 countries around the globe have implemented booster dose programs for tackling omicron endemics. Despite early findings shows that booster doses may improve omicron protection, more research is needed to establish vaccination efficacy. This short communication tries to critically discuss the research work findings around booster dose strategy for omicron endemics.
引用
收藏
页数:6
相关论文
共 35 条
[31]   Emerging evidence on Omicron (B.1.1.529) SARS-CoV-2 variant [J].
Sharma, Vineet ;
Rai, Himanshu ;
Gautam, Dev N. S. ;
Prajapati, Pradeep K. ;
Sharma, Rohit .
JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (05) :1876-1885
[32]  
Sheikh A., 2021, Severity of Omicron variant of concern and vaccine effectiveness against symptomatic disease: national cohort with nested test negative design study in Scotland
[33]   Booster Vaccination to Reduce SARS-CoV-2 Transmission and Infection [J].
Wald, Anna .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 327 (04) :327-328
[34]   Vaccine booster efficiently inhibits entry of SARS-CoV-2 omicron variant [J].
Zhang, Wei ;
Huang, Linfen ;
Ye, Gang ;
Geng, Qibin ;
Ikeogu, Nwando ;
Harris, Morgan ;
Dileepan, Gayathri ;
Burrack, Kristina ;
Du, Lanying ;
Frosch, Anne ;
Li, Fang .
CELLULAR & MOLECULAR IMMUNOLOGY, 2022, 19 (03) :445-446
[35]   SARS-CoV-2 Omicron variant shows less efficient replication and fusion activity when compared with Delta variant in TMPRSS2-expressed cells [J].
Zhao, Hanjun ;
Lu, Lu ;
Peng, Zheng ;
Chen, Lin-Lei ;
Meng, Xinjin ;
Zhang, Chuyuan ;
Ip, Jonathan Daniel ;
Chan, Wan-Mui ;
Chu, Allen Wing-Ho ;
Chan, Kwok-Hung ;
Jin, Dong-Yan ;
Chen, Honglin ;
Yuen, Kwok-Yung ;
To, Kelvin Kai-Wang .
EMERGING MICROBES & INFECTIONS, 2022, 11 (01) :277-283